29 research outputs found
Assessment of asthma severity according to treatment steps in Japanese pediatric patients: a descriptive cross-sectional study using an administrative claims database
No full textCan medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
Get PDFERS International Congress, Madrid, 2019: highlights from the Epidemiology and Environment Assembly
No full textNavafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies
No full textCost-effective treatment, prevention and management of chronic respiratory conditions: A continuing challenge
No full textExploring the potential benefits of digital health technology for the management of COPD: a qualitative study of patient perceptions
No full textVitamin D for the management of chronic obstructive pulmonary disease
Get PDFCopyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. is is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Our primary objectives are to determine whether Vitamin D supplementation reduces the risk of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) requiring systemic corticosteroids, antibiotics or both. Our secondary objectives are to evaluate the impact of Vitamin D supplementation on other effectiveness outcomes, including severe AECOPD, i.e. Those requiring emergency department (ED) attendance or hospitalisation, moderate AECOPD, study-defined AECOPD, adverse events, death, symptom control, industrial absenteeism, self-reported short-acting bronchodilator use, quality of life; physiological and biochemical, including lung function, exercise tolerance, muscle strength, biomarkers of inflammation, costeffectiveness and safety in people with COPD
Estimating mortality among inpatients with acute exacerbation of chronic obstructive pulmonary disease using registry data
No full text
